Author/Authors :
Peterson، نويسنده , , Eric D. and Dai، نويسنده , , David and DeLong، نويسنده , , Elizabeth R. and Brennan، نويسنده , , J. Matthew and Singh، نويسنده , , Mandeep and Rao، نويسنده , , Sunil V. and Shaw، نويسنده , , Richard E. and Roe، نويسنده , , Matthew T. and Ho، نويسنده , , Kalon K.L. and Klein، نويسنده , , Lloyd W. and Krone، نويسنده , , Ronald J. and Weintraub، نويسنده , , William S. and Brindis، نويسنده , , Ralph G. and Rumsfeld، نويسنده , , John S. and Spertus، نويسنده , , John A.، نويسنده ,
Abstract :
Objectives
ght to create contemporary models for predicting mortality risk following percutaneous coronary intervention (PCI).
ound
is a need to identify PCI risk factors and accurately quantify procedural risks to facilitate comparative effectiveness research, provider comparisons, and informed patient decision making.
s
rom 181,775 procedures performed from January 2004 to March 2006 were used to develop risk models based on pre-procedural and/or angiographic factors using logistic regression. These models were independently evaluated in 2 validation cohorts: contemporary (n = 121,183, January 2004 to March 2006) and prospective (n = 285,440, March 2006 to March 2007).
s
l, PCI in-hospital mortality was 1.27%, ranging from 0.65% in elective PCI to 4.81% in ST-segment elevation myocardial infarction patients. Multiple pre-procedural clinical factors were significantly associated with in-hospital mortality. Angiographic variables provided only modest incremental information to pre-procedural risk assessments. The overall National Cardiovascular Data Registry (NCDR) model, as well as a simplified NCDR risk score (based on 8 key pre-procedure factors), had excellent discrimination (c-index: 0.93 and 0.91, respectively). Discrimination and calibration of both risk tools were retained among specific patient subgroups, in the validation samples, and when used to estimate 30-day mortality rates among Medicare patients.
sions
for early mortality following PCI can be accurately predicted in contemporary practice. Incorporation of such risk tools should facilitate research, clinical decisions, and policy applications.